Summary: Findings reveal the molecular mechanism for acetylcholine in learning and memory.
Source: Fujita Health University.
Patients with Alzheimer’s disease (AD) have lower levels of the neuromodulator acetylcholine (ACh) in their brains. Donepezil, an AD drug, increases brain ACh levels and improves AD-associated learning deficits.
Comments are closed.